GC0000200A - Camptothecin derivatives having antitumor activity - Google Patents

Camptothecin derivatives having antitumor activity

Info

Publication number
GC0000200A
GC0000200A GCP2000820A GC0000200A GC 0000200 A GC0000200 A GC 0000200A GC P2000820 A GCP2000820 A GC P2000820A GC 0000200 A GC0000200 A GC 0000200A
Authority
GC
Cooperation Council for the Arab states of the Gulf
Prior art keywords
antitumor activity
camptothecin derivatives
camptothecin
derivatives
antitumor
Prior art date
Application number
Inventor
Paolo Carminati
Franco Zunino
Lucio Merlini
Sergio Penco
Original Assignee
Ist Naz Stud Cura Dei Tumori
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Naz Stud Cura Dei Tumori, Sigma Tau Ind Farmaceuti filed Critical Ist Naz Stud Cura Dei Tumori
Priority to GCP2000820 priority Critical patent/GC0000200A/en
Application granted granted Critical
Publication of GC0000200A publication Critical patent/GC0000200A/en

Links

GCP2000820 2000-08-13 2000-08-13 Camptothecin derivatives having antitumor activity GC0000200A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GCP2000820 GC0000200A (en) 2000-08-13 2000-08-13 Camptothecin derivatives having antitumor activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GCP2000820 GC0000200A (en) 2000-08-13 2000-08-13 Camptothecin derivatives having antitumor activity

Publications (1)

Publication Number Publication Date
GC0000200A true GC0000200A (en) 2006-03-29

Family

ID=37192686

Family Applications (1)

Application Number Title Priority Date Filing Date
GCP2000820 GC0000200A (en) 2000-08-13 2000-08-13 Camptothecin derivatives having antitumor activity

Country Status (1)

Country Link
GC (1) GC0000200A (en)

Similar Documents

Publication Publication Date Title
EG23999A (en) Camptothecin derivatives having antitumor activity
HK1054233A1 (en) Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
HK1066218A1 (en) Qunazoline derivatives as antitumor agents
EG23817A (en) 4-Phenyl-pyridine derivatives
HRP20030306A2 (en) Pyridine derivatives with ikb-kinase (ikk-?) inhibiting activity
PL351611A1 (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agents
MXPA03004644A (en) Phenylacetamido- pyrazole derivatives and their use as antitumor agents.
GC0000183A (en) 3-Phenyl-pyridine derivatives
GC0000338A (en) 5-Phenyl-pyrimidine derivatives
HK1044940A1 (en) Isoxazolecarboxamide derivatives
GC0000191A (en) 4-Phenyl-pyrimidine derivatives
HU0003938D0 (en) Quinolin-4-yl derivatives
IL138777A0 (en) Quinolin-4-yl derivatives i
GB0026485D0 (en) ›-Carboline derivatives
HK1045987A1 (en) 3-amino-2-benzyl-1-phenyl-propane derivatives
GC0000256A (en) Ethanesulfonyl-piperidine derivatives
CZ20011797A3 (en) Pharmaceutical preparation exhibiting antitumor activity
HK1045698A1 (en) Avermectin derivatives
AU2001240024A1 (en) Camptothecin complexes
AP2001002327A0 (en) 1-Trifluoromethyl-4-hydroxy-7- piperidinylaminomethy lchroman derivatives
GB0131034D0 (en) Benzocyclodecane derivatives with antitumor activity
GC0000200A (en) Camptothecin derivatives having antitumor activity
AU5769500A (en) Ucf116 derivatives as antitumor agents
GB9907134D0 (en) Antimor napthylcombretastatin derivatives
HK1043987A1 (en) Thio-oxindole derivatives